Columvi: payments to doctors
Payments that named Columvi as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.1M
- Providers
- 3,412
- Transactions
- 6,288
- Average per transaction
- $167
The per-transaction average — $167 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,412 providers the average total is $308, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Genentech USA, Inc. | $850,820 | 80.9% |
| Genentech, Inc. | $199,407 | 19.0% |
| F. Hoffmann-la Roche AG | $1,640 | 0.2% |